These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34540397)

  • 1. Azithromycin-Induced Bradycardia.
    Abdelazeem B; Hollander RM; Ayad S; Gergis K; Gismalla ME
    Cureus; 2021 Aug; 13(8):e16995. PubMed ID: 34540397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradycardia and Hypothermia Complicating Azithromycin Treatment.
    Benn K; Salman S; Page-Sharp M; Davis TME; Buttery JP
    Am J Case Rep; 2017 Aug; 18():883-886. PubMed ID: 28798290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening bradyarrhythmia after massive azithromycin overdose.
    Tilelli JA; Smith KM; Pettignano R
    Pharmacotherapy; 2006 Jan; 26(1):147-50. PubMed ID: 16506357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study.
    Sears SP; Getz TW; Austin CO; Palmer WC; Boyd EA; Stancampiano FF
    Drugs Real World Outcomes; 2016 Mar; 3(1):99-105. PubMed ID: 27747808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center.
    Lee RA; Guyton A; Kunz D; Cutter GR; Hoesley CJ
    J Hosp Med; 2016 Jan; 11(1):15-20. PubMed ID: 26287278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible Azithromycin-Induced Life-Threatening Arrhythmia Requiring Extracorporeal Membrane Oxygenation Support: A Case Report.
    Al-Jazairi AS; Alotaibi HS
    Am J Case Rep; 2020 Nov; 21():e926951. PubMed ID: 33180749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin.
    Cadle RM; Darouiche RO; Ashton CM
    Ann Pharmacother; 1997 Nov; 31(11):1308-10. PubMed ID: 9391684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline in Treatment of COVID-19 Induced Sinus Bradycardia.
    Sawalha K; Habash FJ; Vallurupalli S; Paydak H
    Clin Pract; 2021 Jun; 11(2):332-336. PubMed ID: 34205865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
    Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
    Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of microminipigs for unveiling unknown mechanisms of azithromycin-induced cardiovascular death.
    Goto A; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Kitta K; Hoshiai K; Chiba K; Ando K; Akie Y; Naito AT; Sugiyama A
    J Pharmacol Sci; 2018 Nov; 138(3):198-202. PubMed ID: 30391117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Bradyarrhythmias: A Case Report With Literature Review.
    Ansari SA; Ansari Y; Khan TMA
    Cureus; 2022 Jan; 14(1):e21552. PubMed ID: 35228917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis.
    Lenehan PJ; Schramm CM; Collins MS
    J Cyst Fibros; 2016 Mar; 15(2):192-5. PubMed ID: 26698953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Holter measurement of QT prolongation in ziprasidone overdose.
    Berling I; Isbister GK; Calver L; Clunas S
    Clin Toxicol (Phila); 2011 Aug; 49(7):694-6. PubMed ID: 21819290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.
    Tisdale JE
    Can Pharm J (Ott); 2016 May; 149(3):139-52. PubMed ID: 27212965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.